Timeline
Last
$29.20
-0.30 (-1.02%)
24HR-1.0%
1W-4.3%
1M-4.6%
1Y+117.9%
Valuation
- Market Cap
- $34B
- Enterprise Value
- $47.3B
- P/E (TTM)
- 56.15x
- Forward P/E
- —
- Price / Sales
- 1.97x
- EV / EBITDA
- 11.07x
Cash Flow
- Operating Cash Flow
- $1.9B
- Free Cash Flow
- $2.2B
- FCF Margin
- 12.8%
- Cash Conversion
- 117.0%
- Cash / Share
- $3.1
Margins & Growth
- Gross Margin
- 52.5%
- Operating Margin
- 4.0%
- EBITDA Margin
- 24.6%
- Net Margin
- 4.1%
- Revenue Growth
- -0.8%
- Earnings Growth
- —
Balance Sheet
- Total Cash
- $3.7B
- Total Debt
- $16.9B
- Net Cash
- -$13.2B
- Debt / Equity
- 2.18x
- Current Ratio
- 0.88x
- Quick Ratio
- 0.46x
Returns & Ownership
- Return on Assets
- 5.1%
- Return on Equity
- 9.7%
- Dividend Yield
- —
- Payout Ratio
- 0.0%
- Beta
- 0.88
- Institutional Ownership
- 62.9%
Latest FY EPS——
Beat rate—0 prints
Avg surprise—vs consensus
Next printJul 29, 2026Estimate pending
Annual EPS vs consensus
0 years Actual ConsensusLabels: beat $ · YoY %
Earnings transcripts
Read management commentary and analyst Q&A.
No transcript dates are available yet for this ticker.
Forward estimates
Consensus expectations and estimate momentum.
PeriodEPSRevenueGrowth
0QSep 2026
—$4.2B—+1QDec 2026
—$4.2B—0YDec 2026
—$16.6B—+1YDec 2027
—$17.3B—Primary research
Recent company filings
Jump directly to earnings releases, quarterly reports, and material updates.
TEV.F stock research · Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and c…
| Last price | $29.2 |
|---|---|
| Day change | -0.30 (-1.02%) |
| Market cap | $34B |
| P/E (TTM) | 56.15x |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |